ARQULE INC
4, 1997-08-11
PHARMACEUTICAL PREPARATIONS
Previous: ARQULE INC, 4, 1997-08-11
Next: ARQULE INC, 4, 1997-08-11



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Dow, Stephen M.
   c/o Sevin Rosen Fund IV L.P.
   Two Galleria Tower
   13455 Noel Road, Suite 1670
   Dallas, TX  75240
2. Issuer Name and Ticker or Trading Symbol
   ArQule, Inc.
   ('ARQL")
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   February 1997
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   (X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock, par value $.0|02/27/|J(1)| |1,542,856         |A  |           |2,353,030          |I     |By Sevin Rosen Fund IV L.P.|
1 per share                |97    |    | |                  |   |           |                   |      | (2)                       |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value $.0|02/27/|J(3)| |24,421            |A  |           |24,421             |I     |By Legomer Investors, Inc. |
1 per share                |97    |    | |                  |   |           |                   |      |(4)                        |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Stock Option (Right to|$11.00  |08/14|    | |7,500      |A  |(5)  |08/14|Common Stock|7,500  |       |7,500       |D  |            |
 Buy)                 |        |/96  |    | |           |   |     |/06  |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  Acquired pursuant to a distribution by ArQule Partners, L.P. to its 
partners.  Prior to the dissolution of ArQule 
Partners, L.P., Sevin Rosen Fund IV L.P. was a limited partner of ArQule 
Partners, L.P.  
(2)  The Reporting Person is a general partner of SRB Associates IV L.P. which 
is the general partner of Sevin 
Rosen Fund IV L.P.   The Reporting Person disclaims beneficial ownership, 
within the meaning of Rule 13d-3 under 
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the 
shares of stock owned by such 
entities except to the extent of his proportionate partnership interest 
therein.
(3)  Aquired pursuant to a distribution by ArQule Partners, L.P. to its 
partners.
(4)  The Reporting Person is the President and a director of Legomer Investors, 
Inc.  Sevin Rosen Fund IV L.P. is a 
majority stockholder in Legomer Investors, Inc. which was a general partner of 
ArQule Partners, L.P.  The Reporting 
Person disclaims beneficial ownership, within the meaning of Rule 13d-3 under 
the Exchange Act, of the shares of 
stock owned by Legomer Investors, Inc., except to the extent of his pecuniary 
interest therein.
(5)  This option will become exercisable at the rate of 2,500 shares on the 
date of each of the 1997, 1998 and 1999 
annual meetings of stockholders of the 
Issuer.
SIGNATURE OF REPORTING PERSON
/s/ John V. Jaggers, as Attorney-in-Fact
DATE
August 11, 1997



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission